Table 3 Details of the spending, considering the most representative cost items
From: Pediatric unit spending in the North of Italy during the COVID-19 pandemic
2018 | Emergency Room | Pediatric Ward | Day Hospital | Rare Disease center | Outpatient Ambulatory | Direct drug distribution |
Medical Devices | 88.1% | 16.7% | 2.1% | - | 96.6% | - |
% diabetes technology | - | - | - | - | 95.2% | - |
% COVID-19 related | - | - | - | - | - | - |
Drugs | 8.9% | 78.3% | 97% | - | 1.1% | 99.9% |
% biologic | - | 64.9% | 97.6% | - | - | 85.8% |
Other Health care product | 2.9% | 5% | 0,9% | - | 2.3% | - |
Total spending (euros) | 76.001 | 363.043 | 1.230.248 | - | 414.781 | 93.244 |
2019 | Emergency Room | Pediatric Ward | Day Hospital | Rare Disease center | Outpatient Ambulatory | Direct drug distribution |
Medical Devices | 87.5% | 41.3% | 1.8% | - | 97.6% | - |
% diabetes technology | - | - | - | - | 98.9% | - |
% COVID-19 related | - | - | - | - | - | - |
Drugs | 9.7% | 48.4% | 97.8% | 99.9% | 0.9% | 100% |
% biologic | - | 25.2% | 98% | 99.6% | - | 83.1% |
Other Health care product | 2.8% | 10.3% | 0,4% | 0.01% | 1.5% | - |
Total spending (euros) | 86.589 | 190.725 | 1.222.751 | 315.083 | 590.646 | 50.246 |
2020 | Emergency Room | Pediatric Ward | Day Hospital | Rare Disease center | Outpatient Ambulatory | Direct drug distribution |
Medical Devices | 93.1% | 30.3% | 6.9% | - | 95.1% | - |
% diabetes technology | - | - | - | - | 99.9% | - |
% COVID-19 related | 51% | 59% | 3.5% | - | - | |
Drugs | 3.7% | 47.8% | 88.9% | 99.9% | 1.4% | 100% |
% biologic | - | 28.6% | 95.6% | 98.7% | - | 80.2% |
Other Health care product | 3,2% | 21.9% | 4,2% | 0.01% | 3,5% | - |
Total spending (euros) | 134.305 | 263.407 | 662.806 | 717.291 | 650.143 | 43.052 |
2021 | Emergency Room | Pediatric Ward | Day Hospital | Rare Disease center | Outpatient Ambulatory | Direct drug distribution |
Medical Devices | 83.3% | 19.6% | 8.1% | - | 97.7% | - |
% diabetes technology | - | - | - | - | 97% | - |
% COVID-19 related | 54% | 18% | 3% | - | - | - |
Drugs | 3.7% | 65.4% | 86.3% | 99.8% | 1.4% | 100% |
% biologic | - | 57% | 74% | 95% | - | 76% |
Other Health care product | 13% | 7% | 5,6% | 0.02% | 0.9% | - |
Total spending (euros) | 166.473 | 423.418 | 308.815 | 417.077 | 780.992 | 44.465 |
2022 | Emergency Room | Pediatric Ward | Day Hospital | Rare Disease center | Outpatient Ambulatory | Direct drug distribution |
Medical Devices | 91% | 33.7% | 12% | - | 97% | - |
% diabetes technology | - | - | - | - | 97% | - |
% COVID-19 related | 68% | 22% | 2% | - | - | - |
Drugs | 3.1% | 44% | 74.3% | 99.9% | 1.6% | 100% |
% biologic | - | 21% | 65% | 98% | - | 52% |
Other Health care product | 5.9% | 22.3% | 13,7% | 0.01% | 1.4% | - |
Total spending (euros) | 240.144 | 216.583 | 125.424 | 599.889 | 917.986 | 47.503 |